China Traditional Chinese Medicine Holdings Co., often referred to as China TCM, is a prominent player in the traditional Chinese medicine industry, headquartered in China (CN). Established in 2001, the company has made significant strides in promoting the benefits of traditional herbal remedies and therapies across major operational regions, including Asia and beyond. Specialising in the research, development, and distribution of traditional Chinese medicinal products, China TCM offers a unique range of herbal formulations and health supplements that are rooted in centuries-old practices. The company is recognised for its commitment to quality and innovation, ensuring that its products meet rigorous health standards. With a strong market position, China TCM has achieved notable milestones, including strategic partnerships and a growing international presence, solidifying its reputation as a leader in the traditional medicine sector.
How does China Traditional Chinese Medicine Holdings Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
China Traditional Chinese Medicine Holdings Co's score of 40 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, China Traditional Chinese Medicine Holdings Co. reported total carbon emissions of approximately 237,619,200 kg CO2e, comprising about 104,425,200 kg CO2e from Scope 1 and about 133,194,000 kg CO2e from Scope 2 emissions. In 2023, the company recorded total emissions of about 338,793,600 kg CO2e, with Scope 1 emissions at approximately 106,562,200 kg CO2e and Scope 2 emissions at about 232,231,400 kg CO2e. The company has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. Notably, there are no specific reduction targets or climate pledges outlined in their current commitments, suggesting that while emissions data is available, formalised climate initiatives may be lacking. The emissions data is sourced directly from China Traditional Chinese Medicine Holdings Co. Limited, with no cascading from a parent or related organisation. The company operates within the traditional Chinese medicine sector, which may face increasing scrutiny regarding sustainability practices and carbon footprint management.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 50,450,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 67,648,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
China Traditional Chinese Medicine Holdings Co has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
